FDA says Novartis withheld data problem before drug’s approval
Published: August 8, 2019
TRENTON, N.J. (AP) — U.S. regulators want to know why Novartis didn’t disclose a problem with testing data until after the Swiss drugmaker’s $2.1 million gene...
